Advancing Science to Transform Lives
Astellas Oncology is moving cancer treatment forward for patients and their loved ones. We develop novel, targeted therapies and support promising research to discover new care pathways. Through strategic collaboration with all members of the cancer community, Astellas Oncology brings leading treatments to patients who need them.
It’s Your Turn to
Change Cancer Care
The Astellas Oncology C3 Prize is a challenge designed to inspire novel, non-treatment and non-medicine based innovations that improve the cancer care experience for patients, caregivers and loved ones.
The C3 Prize is back with a new challenge launching in 2017; stay tuned to www.C3Prize.com to learn more.
A Selective Approach to R&D
Astellas Oncology pursues targeted therapies for hard-to-treat cancers with few therapeutic options.
Astellas Oncology focuses on discovering and developing treatments to address the unmet needs of cancer patients who are facing one of life's most challenging health issues. Our current in-line therapeutic areas include prostate cancer, non-small cell lung cancer and pancreatic cancer.
Together with our strategic partners, Astellas Oncology develops and markets cancer therapies and is working to discover new pathways to care.
Advocacy in Action
Astellas Oncology engages with stakeholders across the cancer community to support advocacy, education and support.
- Astellas Names Shontelle Dodson Senior Vice President and Head of Medical Affairs Americas
- Astellas Announces Decision to Discontinue ASP8273 Treatment Arm and Close Randomization for Clinical Study Protocol 8273-CL-0302
- Astellas Recognized as a Top Employer by Forbes Magazine for the Third Consecutive Year